Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus

被引:72
作者
Caffrey, Tara M. [1 ]
Joachim, Catharine [2 ,3 ]
Wade-Martins, Richard [1 ]
机构
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Neuropathol, Oxford OX3 9DU, England
[3] Oxford Ctr Gene Funct, Dept Physiol Anat & Genet, Oxford Project Investigate Memory & Ageing OPTIMA, Oxford OX1 3PT, England
基金
英国惠康基金;
关键词
MAPT; tau; MAPT haplotype; Progressive supranuclear palsy; Corticobasal degeneration; Allele-specific expression; Tauopathy; Alternative splicing;
D O I
10.1016/j.neurobiolaging.2007.05.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
The microtubule-associated protein tau (MAPT) H1 haplotype shows a strong association to the sporadic neurodegenerative diseases, progressive supranuclear palsy and corticobasal degeneration. The functional biological mechanisms behind the genetic association have started to emerge with differences recently shown in haplotype splicing of the neuropathologically relevant exon 10. Here we investigate the hypothesis that expression of the alternatively spliced N-terminal exon also differs between the two MAPT haplotypes. We performed allele-specific gene expression analysis on a H1/H2 heterozygous human neuronal cell line model and 14 H1/H2 heterozygous human post-mortem brain tissues from two brain regions. In both cell culture and post-mortem brain tissue, we show that the protective MAPT H2 haplotype significantly expresses two-fold more 2N (exons 2+3+) MAPT transcripts than the disease-associated H1 haplotype. We suggest that inclusion of exon 3 in MAPT transcripts may contribute to protecting H2 carries from neurodegeneration. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1923 / 1929
页数:7
相关论文
共 36 条
[1]
Arai T, 2001, ACTA NEUROPATHOL, V101, P167
[2]
Association of an extended haplotype in the tau gene with progressive supranuclear palsy [J].
Baker, M ;
Litvan, I ;
Houlden, H ;
Adamson, J ;
Dickson, D ;
Perez-Tur, J ;
Hardy, J ;
Lynch, T ;
Bigio, E ;
Hutton, M .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :711-715
[3]
Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease [J].
Boutajangout, A ;
Boom, A ;
Leroy, K ;
Brion, JP .
FEBS LETTERS, 2004, 576 (1-2) :183-189
[4]
INTERACTION OF TAU WITH THE NEURAL PLASMA-MEMBRANE MEDIATED BY TAU AMINO-TERMINAL PROJECTION DOMAIN [J].
BRANDT, R ;
LEGER, J ;
LEE, G .
JOURNAL OF CELL BIOLOGY, 1995, 131 (05) :1327-1340
[5]
Cis-acting variation in the expression of a high proportion of genes in human brain [J].
Bray, NJ ;
Buckland, PR ;
Owen, MJ ;
O'Donovan, MC .
HUMAN GENETICS, 2003, 113 (02) :149-153
[6]
Haplotype-specific expression of exon 10 at the human MAPT locus [J].
Caffrey, Tara M. ;
Joachim, Catharine ;
Paracchini, Silvia ;
Esiri, Margaret M. ;
Wade-Martins, Richard .
HUMAN MOLECULAR GENETICS, 2006, 15 (24) :3529-3537
[7]
PROJECTION DOMAINS OF MAP2 AND TAU DETERMINE SPACINGS BETWEEN MICROTUBULES IN DENDRITES AND AXONS [J].
CHEN, J ;
KANAI, Y ;
COWAN, NJ ;
HIROKAWA, N .
NATURE, 1992, 360 (6405) :674-676
[8]
Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells [J].
Encinas, M ;
Iglesias, M ;
Liu, YH ;
Wang, HY ;
Muhaisen, A ;
Ceña, V ;
Gallego, C ;
Comella, JX .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :991-1003
[9]
FEANY MB, 1995, ACTA NEUROPATHOL, V90, P37
[10]
Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy [J].
Gibb, GM ;
de Silva, R ;
Revesz, T ;
Lees, AJ ;
Anderton, BH ;
Hanger, DP .
MOLECULAR BRAIN RESEARCH, 2004, 121 (1-2) :95-101